Evidence map›Paper›PMID 16864052›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2006

T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease.

Christine G DiRienzo, George F Murphy, Stephen C Jones, Robert Korngold, Thea M Friedman

Open access · hybridAbstract read
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching.International journal of hematology-oncology and stem cell research · 2025
    Article
  2. Review
  3. Article
  4. Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.American journal of clinical dermatology · 2018
    Review
  5. [Cutaneous graft-versus-host disease].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. T-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Christine G DiRienzoDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
George F Murphy
Stephen C Jones
Robert Korngold
Thea M Friedman
Thomas Jefferson University · USHackensack University Medical Center · USHarvard University · US

Funding

ETIOLOGY &PATHOGENESIS OF MURINE GRAFT-VS-HOST DISEASER01HL055593 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI KORNGOLD, ROBERT · 1995 to 2009
$3.4M
CELLULAR PATHOLOGY OF GRAFT VERSUS HOST DISEASER01CA040358 · NCI · UNIVERSITY OF PENNSYLVANIA · PI MURPHY, GEORGE F · 1985 to 2001
$441k
NCI NIH HHS CA-40358NCI NIH HHS R01 CA040358NHLBI NIH HHS HL-55593NHLBI NIH HHS HL-98895NHLBI NIH HHS R01 HL055593
6 · The paper itself

Abstract

Although CD4(+) T cells can have an important role in mediating lethal graft-versus-host disease (GVHD) directed to multiple minor histocompatibility antigens (miHA) after bone marrow transplantation, their precise characterization and effector function remains elusive. In this regard, T cell receptor (TCR) Vbeta spectratype analysis has been a powerful tool for identifying donor CD4(+) T cell populations expanding to host miHA after bone marrow transplantation in the major histocompatibility complex-matched C57BL/6 (B6) --> C.B10-H2(b) (BALB.B) model of lethal GVHD. Removal of all of the Vbeta(+) T cell families containing these responding cells from the donor inoculum has proven to be an effective means of preventing the development of GVHD. Previous studies have also found that of the 11 miHA-responsive B6 CD4(+) Vbeta(+) T cell families, transplantation of Vbeta2(+) and Vbeta11(+) T cells together into lethally irradiated BALB.B mice appeared to be primarily responsible for the severity of resultant GVHD. Further focusing on these critical CD4 responses, in this study we demonstrate that B6 CD4(+)Vbeta11(+) T cells alone can induce lethal GVHD in BALB.B recipients. In addition, immunohistochemical staining of host lingual and intestinal epithelial tissues supported the capacity of Vbeta11(+) T cells to infiltrate typical GVHD-associated target areas. To further characterize the specific CD4(+)Vbeta11(+) T cells involved in this anti-miHA response, TCR Valpha spectratype analysis was performed and indicated that 6 Valpha chains were used by this reactive population. These results provide further evidence that a restricted repertoire of T cell specificities, presumably recognizing a correspondingly low number of miHA, is sufficient for the induction of severe GVHD.

Indexed as

AnimalsCD4-Positive T-LymphocytesFemaleGene Rearrangement, alpha-Chain T-Cell Antigen ReceptorGraft vs Host DiseaseMaleMiceMinor Histocompatibility AntigensReceptors, Antigen, T-Cell, alpha-betaSeverity of Illness IndexMinor Histocompatibility AntigensReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID16864052
PMCPMC2602873
OpenAlexW2006824039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.